Search

Author/Creator Rashbaum, Bruce

1. 541. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Treatment Naïve Patients: Week 48 Results in Subgroups Based on Baseline Viral Load, CD4+ Count, and WHO Clinical Staging. (26th November 2018)

Authors:
Spinner, Christoph D; Rashbaum, Bruce; Mcdonald, Cheryl; Mussini, Cristina; Luo, Donghan; Jezorwski, John; Brown, Kimberley; Wong, Eric Y
Journal:
Open forum infectious diseases
Issue:
Volume 5(2018)Supplement 1
Page Start:
S201
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment. (1st May 2016)

Authors:
Wohl, David; Oka, Shinichi; Clumeck, Nathan; Clarke, Amanda; Brinson, Cynthia; Stephens, Jeffrey; Tashima, Karen; Arribas, Jose R.; Rashbaum, Bruce; Cheret, Antoine; Brunetta, Jason; Mussini, Cristina; Tebas, Pablo; Sax, Paul E.; Cheng, Andrew; Zhong, Lijie; Callebaut, Christian; Das, Moupali; Fo...
Journal:
Journal of acquired immune deficiency syndromes
Issue:
Volume 72:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study. Issue 1 (2nd January 2019)

Authors:
Rashbaum, Bruce; Spinner, Christoph D.; McDonald, Cheryl; Mussini, Cristina; Jezorwski, John; Luo, Donghan; Van Landuyt, Erika; Brown, Kimberley; Wong, Eric Y.
Journal:
HIV research & clinical practice
Issue:
Volume 20:Issue 1(2019)
Page Start:
24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in HIV-infected, Virologically Suppressed Black and Non-Blacks Adults Through Week 96: Subgroup Analysis of a Randomized Switch Study. (4th October 2017)

Authors:
Flamm, Jason A; Vanig, Thanes; Gathe, Joseph; Kinder, Clifford; Para, Michael; Rashbaum, Bruce; Segal-Maurer, Sorana; Shamblaw, David; Wohlfeiler, Michael; Young, Benjamin; Zurawski, Christine; Rhee, Martin S
Journal:
Open forum infectious diseases
Issue:
Volume 4(2017)Supplement 1
Page Start:
S427
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021)

Authors:
Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason...
Journal:
Lancet
Issue:
Volume 8:Issue 7(2021)
Page Start:
e397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗